EUVIMEDSkopri EUVIMED
Open access · CC BY-NC-ND 4.0

Peptide ligands for the affinity purification of adeno‐associated viruses from HEK 293 cell lysates

Wenning Chu iD, Shriarjun Shastry, Eduardo Barbieri, Raphael Prodromou, Paul Greback-Clarke, Will Smith, Brandyn Moore, Ryan Kilgore, Christopher Cummings, Jennifer Pancorbo, Gary Gilleskie iD, Michael A Daniele and 1 more

Biotechnology and Bioengineering · 2023-08 · 120 (8) · 2283-2300

DOI: 10.1002/bit.28495 ↗

At a glance

Journal article in Biotechnology and Bioengineering, published online on 2023-07-12. Written by Wenning Chu and 12 co-authors. Institution: Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina, USA. Major MEDLINE topics: Dependovirus, Peptides. Cited 35 times so far (Crossref); 106 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: FDA HHS.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Adeno‐associated viruses (AAVs) are the vector of choice for delivering gene therapies that can cure inherited and acquired diseases. Clinical research on various AAV serotypes significantly increased in recent years alongside regulatory approvals of AAV‐based therapies. The current AAV purification platform hinges on the capture step, for which several affinity resins are commercially available. These adsorbents rely on protein ligands—typically camelid antibodies—that provide high binding capacity and selectivity, but suffer from low biochemical stability and high cost, and impose harsh elution conditions (pH < 3) that can harm the transduction activity of recovered AAVs. Addressing these challenges, this study introduces peptide ligands that selectively capture AAVs and release them under mild conditions (pH = 6.0). The peptide sequences were identified by screening a focused library and modeled in silico against AAV serotypes 2 and 9 (AAV2 and AAV9) to select candidate ligands that target homologous sites at the interface of the VP1‐VP2 and VP2‐VP3 virion proteins with mild binding strength ( K D ~ 10 −5 –10 − 6 M). Selected peptides were conjugated to Toyopearl resin and evaluated via binding studies against AAV2 and AAV9, demonstrating the ability to target both serotypes with values of dynamic binding capacity (DBC 10% > 10 13 vp/mL of resin) and product yields (~50%–80%) on par with commercial adsorbents. The peptide‐based adsorbents were finally utilized to purify AAV2 from a HEK 293 cell lysate, affording high recovery (50%–80%), 80‐ to 400‐fold reduction of host cell proteins (HCPs), and high transduction activity (up to 80%) of the purified viruses.

Subjects

MeSH terms (MEDLINE)

DependovirusPeptidesHumansHEK293 CellsLigandsAmino Acid SequenceGenetic Vectors

Author keywords

HEK 293 lysateadeno-associated virusaffinity chromatographypeptide ligandsvirus purification

Substances

LigandsPeptides

Authors and institutions

  • Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina, USA.
  • Biomanufacturing Training and Education Center (BTEC), North Carolina State University, Raleigh, North Carolina, USA.
  • North Carolina Viral Vector Initiative in Research and Learning (NC-VVIRAL), North Carolina State University, Raleigh, North Carolina, USA.
  • Joint Department of Biomedical Engineering, North Carolina State University and University of North Carolina at Chapel Hill, Raleigh, North Carolina, USA.
  • LigaTrap Technologies LLC, Raleigh, North Carolina, USA.

ORCID profiles: Wenning Chu, Gary Gilleskie, Stefano Menegatti

Funding

  • FDA HHS

Cite

APA

Chu, W., Shastry, S., Barbieri, E., Prodromou, R., Greback-Clarke, P., Smith, W., Moore, B., Kilgore, R., Cummings, C., Pancorbo, J., Gilleskie, G., Daniele, M. A., & Menegatti, S. (2023). Peptide ligands for the affinity purification of adeno‐associated viruses from HEK 293 cell lysates. Biotechnology and Bioengineering, 120(8), 2283-2300. https://doi.org/10.1002/bit.28495

Vancouver

Chu W, Shastry S, Barbieri E, Prodromou R, Greback-Clarke P, Smith W, et al. Peptide ligands for the affinity purification of adeno‐associated viruses from HEK 293 cell lysates. Biotechnology and Bioengineering. 2023;120(8):2283-2300. doi:10.1002/bit.28495

BibTeX
@article{Chu2023,
  author = {Chu, Wenning and Shastry, Shriarjun and Barbieri, Eduardo and Prodromou, Raphael and Greback-Clarke, Paul and Smith, Will and Moore, Brandyn and Kilgore, Ryan and Cummings, Christopher and Pancorbo, Jennifer and Gilleskie, Gary and Daniele, Michael A and Menegatti, Stefano},
  title = {Peptide ligands for the affinity purification of adeno‐associated viruses from HEK 293 cell lysates},
  journal = {Biotechnology and Bioengineering},
  year = {2023},
  volume = {120},
  number = {8},
  pages = {2283--2300},
  doi = {10.1002/bit.28495}
}
Start for free →